dr. burger on ovarian cancer maintenance therapy with bevacizumab
Published 11 years ago • 205 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:40
dr. burger on the toxicity profile of bevacizumab in ovarian cancer
-
1:08
dr. burger on the use of bevacizumab in ovarian cancer
-
3:47
frontline bevacizumab strategies in ovarian cancer
-
3:47
extended maintenance therapy in ovarian cancer
-
4:25
adjuvant chemotherapy bevacizumab for ovarian cancer
-
5:55
maintenance therapy: parp inhibitor or bevacizumab
-
3:42
parp maintenance bevacizumab in ovarian cancer
-
2:18
dr. jason a. konner on bevacizumab in advanced ovarian cancer
-
2:08
maintenance therapy in stage iiic ovarian cancer
-
7:19
combination therapy with niraparib and bevacizumab for ovarian cancer
-
2:15
toxicities associated with rucaparib for the treatment of ovarian cancer
-
8:15
bevacizumab in ovarian cancer
-
1:05
dr. essel discusses long-term bevacizumab in ovarian cancer
-
4:23
comment: parp inhibitor olaparib plus bevacizumab in women with ovarian cancer
-
6:34
bevacizumab’s value in recurrent ovarian cancer
-
1:40
dr. hardesty on bevacizumab/parp inhibitor combination in ovarian cancer
-
7:24
ovarian cancer: maintenance following frontline bevacizumab
-
2:36
managing toxicities in advanced ovarian cancer
-
3:16
dr. michael birrer on bevacizumab in ovarian cancers